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Abstract: Two by-products containing phenols and polysaccharides, a “pâté” (OP) from the extra
virgin olive oil milling process and a decoction of pomegranate mesocarp (PM), were investigated
for their effects on human microbiota using the SHIME® system. The ability of these products to
modulate the microbial community was studied simulating a daily intake for nine days. Microbial
functionality, investigated in terms of short chain fatty acids (SCFA) and NH4+, was stable during the
treatment. A significant increase in Lactobacillaceae and Bifidobacteriaceae at nine days was induced by
OP mainly in the proximal tract. Polyphenol metabolism indicated the formation of tyrosol from
OP mainly in the distal tract, while urolithins C and A were produced from PM, identifying the
human donor as a metabotype A. The results confirm the SHIME® system as a suitable in vitro tool
to preliminarily investigate interactions between complex botanicals and human microbiota before
undertaking more challenging human studies.
Keywords: food by-products; human gut; microbial community; tyrosol; ellagitannins
1. Introduction
In 2011, the Food and Agriculture Organization (FAO) of the United Nations reported that
“one-third of the edible parts of food produced for human consumption gets lost or wasted globally,
which is about 1.3 billion tons per year”. Post-harvesting and processing are responsible for more than
40% of losses, mainly in industrial countries [1]. In recent years, interest in food waste valorization and
reuse has grown dramatically and more and more often these materials are more correctly defined
as by-products. The goal of researchers and companies is to define new sustainable processes to
efficiently recover bioactive compounds from normally discarded food by-products, and among the
various matrices, those deriving from the processing of pomegranate and olive fruits are recognized as
particularly interesting.
Different strategies have been proposed to manage wastewaters and pomaces derived from
milling processes to reduce their negative effects, and also to recover the bioactive phenols [2–5]. It has
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been demonstrated that less than 1% of total phenolic compounds in olives is recovered in virgin oil
during the milling process [6]. An interesting semisolid pomace from a two-phase olive mill is the
by-product named pâté. This dry product showed antiaging activity in human cultured cells and can
provide a high daily intake of phenolic constituents: approximately 1 g can contain the same amount
of phenols present in 200 mL of a good quality extra virgin olive oil [7].
Analogously to olive oil by-products, the discarded parts of pomegranate fruit have also been the
object of increased interest, particularly to recover the ellagitannins known as the typical constituents
abundant in the external parts of the fruit discarded during juice production [8]. Several extractions
have been proposed to maximize the recovery of ellagitannins [9] and polysaccharides [10] from the
peel of the pomegranate, a by-product that can include up to 50% of the entire weight of fresh fruit [11].
It has been estimated that, after introduction into the organism through oral administration,
only 5–10% of low molecular weight polyphenols are absorbed in the small intestine, mostly derived
from deconjugation and deglycosylation reactions [12]. High molecular weight polyphenols, such
as the ellagitannins, are not absorbed in the small intestine but reach the colon where they are
metabolized [13]. The metabolism of polyphenols is strictly related to individual gut microbial
composition. This variability leads to different enzymatic and metabolic pathways, which allow
definition of a potential classification in enterotypes or nutritional phenotypes [14]. The advanced
in vitro gastrosimulator system, SHIME, has already been applied to develop numerous studies
focused on investigating the impact of different phenols on human microbiota [15,16]. The potential
positive impact of phenolic compounds is strongly related to interindividual variability of microbial
composition [17]. Polyphenols can influence bacterial growth and metabolism, depending on their
structure, dose, and type of microorganisms considered [18], and can exert antimicrobial activity
in a dose-dependent manner [19]. After exposure to polyphenols, microbial synthesis of defensive
proteins increases, but at the same time their metabolic activity decreases, reducing the formation of
biosynthetic proteins, amino acids, phospholipids, and short chain fatty acids (SCFAs) [13]. Furthermore,
polyphenols exhibited antimicrobial activity against viruses, pathogenic bacteria, and fungi [20], but
the mechanisms that lead to changes in the gut microbial community are strictly related to the chemical
transformations that polyphenols undergo at the gut level. It has been widely demonstrated that
there is a mutual interaction between the structural transformation of polyphenols performed by some
bacteria and the different activities that such molecules should exert on the microbial community,
since in some cases, the phenolic metabolites show higher antimicrobial activity or bioavailability
with respect to their originators [21,22]. However, the in vitro systems currently applied in these
studies reveal some limitations, since other aspects should be considered, such as the genetic and
metabolic state of the host and the interaction of polyphenols with other dietary components [21,23].
Further efforts could be helpful to better clarify the mechanisms involved in the relationship between
polyphenols and intestinal microbiota.
Gut microbiota has been recognized as a key factor in the health effects of pomegranate
ellagitannins [24]; ellagic acid is released in the intestinal lumen by hydrolysis reactions of ellagitannins,
and it is metabolized by bacteria in the large intestine and transformed into urolithins [25,26]. Urolithins
have been found in fecal samples after oral administration of pomegranate juice [27], identifying three
“enterotypes”, and also according to the urolithin profile in the urine [16,28].
Differently from pomegranate, the interaction of the main polyphenols from olive oil is still
scarcely known, and there is little data regarding colonic transformation of these molecules [29–32].
The present study focuses on the effects on intestinal microbiota of two samples derived from
well-known agricultural by-products using the advanced bowel simulator SHIME®. The final aim is
to propose these by-products as potential sources of food ingredients with beneficial effects on human
health. A further aim of this study is to sustain the suitability of a gastro-intestinal simulator such
as SHIME® for a preliminary evaluation of the safety of these new products. The obtained results in
terms of toxicity, biotransformation, and mutual relationship between polyphenols and gut microbiota
can be very useful to provide new insights before performing in vivo trials, which clearly have many
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limitations such as ethical and economic issues and require long times. The chosen samples obtained by
simple and green procedures were an olive pâté (OP) recovered from extra virgin olive oil production
and a decoction from pomegranate mesocarp (PM) of the Wonderful variety. The main objective
of the study was to evaluate the effect of repeated feeding with PM or OP on human microbiota.
The microbial functionality was investigated, determining SCFAs and NH4+ levels and microbiota
composition by Illumina on bacterial DNA. Furthermore, polyphenols’ metabolic fate was studied by
HPLC/DAD/MS analysis.
2. Results and Discussion
2.1. List of Abbreviations
Throughout the test, some abbreviations are used as references to define thedifferent samples.
PCC is proximal colon control; DCC is distal colon control; PPCP is proximal colon olive pâté; DCOP is
distal colon olive pâté day; PCPM is proximal colon pomegranate mesocarp; DCPM is distal colon
pomegranate mesocarp. Day × referes to sampling day (0, 5, 9, 13).
2.2. Experiment Design and OP and PM Composition
The experiments were performed to investigate the mutual effects between the microbial
community and the two samples that can be proposed as new functional ingredients in food formulation.
Since human studies are difficult to manage mainly due to recruiting and compliance, ethical committee
authorization, and real costs, the availability of a dynamic gastrointestinal simulator can be a very
useful tool for preliminary screenings. The final aim of this study is to demonstrate that a possible use of
OP and PM as new food ingredients is without risks (e.g., antimicrobial effects) for human microbiota.
The pomegranate extract is a combination of bioactive compounds containing ellagitannins and
polysaccharides with in vitro prebiotic activity [10], a combination tested for the first time on the
SHIME® system. The olive extract selected in this work has already shown the ability to modify the
microbiota when used as an additive in animal feed [33], but it has never been evaluated with human
gut microbiota.
In this study, the target was mainly to investigate the effect of the administration of repeated daily
doses of the extract, simulating the usual intake of a food or dietary supplement for a long period.
The phenolic composition of PM and OP is summarized in Table 1, where the fiber content of the
two samples is also reported. The design of the experiment (Figure 1) requiring the use of two gastro
simulators in a parallel way mimicked a long trial with one donor instead of multiple donors each with
only one dose. The main phenols in OP were a group of oleuropein derivatives, free hydroxytyrosol,
with minor amounts of verbascoside and luteolin, while the fiber content resulted in 20.4% of insoluble
and 3.7% of soluble dietary fiber; monosaccharides and protein content were assessed at 16.8% and 9%,
respectively. For PM, the analysis indicated α + β punicalagins as the main ellagitannins (70.7 mg/g),
in co-presence with ellagic acid but in lower concentration (3.67 mg/g). Polysaccharide content in PM
(soluble + insoluble fiber) was approximately 10%, and in accordance with the literature was mainly
constituted by pectin [10,34–36].
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Table 1. Composition of the two extracts: (a) polyphenol content and (b) proximate data.
(a)
Sample Phenols mg/g DW
OP
Verbascoside 4.52
Hydroxytyrosol 15.3
Oleuropein derivatives 77.8
Luteolin 0.42
Total polyphenols 97.6
PM
α + β punicalagins 70.7
Ellagic acid and derivatives 10.7
Total ellagitannins 120.2
(b)
Applied Method OP PM
Insoluble fiber AOAC Official Method 991.43 (Total, Soluble,
and Insoluble Dietary Fiber in Foods)
20.4% 3.0%
Soluble fiber 3.7% 6.7%
Proteins
ISTISAN 96/34
Analytical methods used in food
chemical control
9% 2.3%
Total sugars 16.8% 44%
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The metabolic activity of bacteria was investigated through quantitative analysis of SCFA and 
NH4+ concentrations, and the resulting charts are shown in Figure 2A as mean values. 
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2.3. Effects on Microbial Metabolism: SCFA and NH4+
The metabolic activity of bacteria was investigated through quantitative analysis of SCFA and
NH4+ concentrations, and the resulting charts are shown in Figure 2A as mean values.
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Figure 2. A) Short chain fatty acid (SCFA) levels during and after treatment in PC and DC from 
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SCFA (●). B) NH4+ levels during and after treatment in PC (□) and DC (∆), from control, OP-, and 
PM-treated vessels. 
SCFA levels showed quite a regular trend in control vessels, except for the intrinsic variability 
of the system. Overall concentrations in DC samples were higher than in PC ones, but the evolution 
was consistent; similar behavior occurred for NH4+ concentrations in both DC and PC vessels. 
Samples from vessels treated with OP showed a trend comparable to the control, in both 
proximal and distal vessels, and no relevant changes were recorded during or after the treatment. As 
expected, according to the prevalent content of insoluble fiber, recognized as a non-fermentable or 
scarcely fermentable substrate, SCFA production was not modified with respect to the control. Only 
a small decrease was observed after the end of the treatment, particularly in DC, because interruption 
of administration affected functionality, which needed two days to go back to starting levels. 
In PC vessels treated with PM, a weak increment in SCFA levels was observed up to nine days, 
with a physiological reduction after the end of administration and a new increase, close to starting 
values, after washout. In the DC vessel, only a weak but not relevant decrease of concentrations was 
highlighted. Differently from the OP extract, the PM decoction produced a weak prebiotic effect, 
probably due to its polysaccharides being mainly constituted by pectin that exhibited prebiotic 
properties in vitro [10,37]. Recent studies demonstrated the capacity of pectin to promote the growth 
of colonic Bacterioidetes, but only few data refer to Firmicutes [38–40]. Among the Firmicutes, the 
growth of Eubacterium eligens was promoted specifically by different apple pectin, which were 
hydrolyzed by a constitutive pectate lyase [40]. Studies on the specific effects of pectin from 
pomegranate fruits on human microbiota have not been available until now. 
Figure 2. (A) Short chain fatty acid (SCFA) levels during and after treatment in PC and DC from
control, OP- and PM-treated vessels in terms of acetate (∆), propionate (), butyrate (♦), and total
SCFA (•). (B) NH4+ levels during and after treatment in PC () and DC (∆), from control, OP-, and
PM-treated vessels.
SCFA levels showed quite a regular trend in control vessels, except for the intrinsic variability of
the system. Overall concentrations in DC samples were higher than in PC ones, but the evolution was
consistent; similar behavior occurred for NH4+ concentrations in both DC and PC vessels.
Samples from vessels treated with OP showed a trend comparable to the control, in both proximal
and distal vessels, and n relevant changes were rec rded du ing r aft r the treatment. As expected,
according to the prevalent content of insoluble fiber, recognized as a non-fermentable or scarcely
fermentable substrate, SCFA production was not modified with respect to the control. Only a small
decrease was observed after the end of the treatment, particularly in DC, because interruption of
administration affected functionality, which needed two days to go back to starting levels.
In PC vessels treated with PM, a weak increment in SCFA levels was observed up to nine days,
with a physiological reduction after the end of administration and a new increase, close to starting
values, after washout. In the DC vessel, only a weak but not relevant decrease of concentrations
was highlighted. Differently from the OP extract, the PM decoction produced a w ak prebiotic
effect, pr bably du t its polysaccharides being mainly constituted by pecti that exhibited prebiotic
properties in vitro [10,37]. Recent studies demonstrated the capacity of pectin to promote the growth
of colonic Bacterioidetes, but only few data refer to Firmicutes [38–40]. Among the Firmicutes, the growth
of Eubacterium eligens was promoted specifically by different apple pectin, which were hydrolyzed by
a constitutive pectate lyase [40]. Studies on the specific effects of pectin from po egranate fruits on
human microbiota have not been available until now.
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Over time, NH4+ levels were comparable to those of the control during treatment and washout
for both OP and PM (Figure 2B), indicating the system was stable with only weak variability.
A preliminary experiment was also carried out using a no-carbohydrate medium in the SHIME®
vessels, and the SCFA production was studied (Supplementary Materials Figure S1). OP administered
samples presented a different trend compared with the control: in both PC and DC, an increase of
SCFA level was recorded during the treatment period and concentrations rose about 50%, meaning
that OP was used as a carbon source by the bacterial community. Treatment with PM highlighted a
similar trend; in the PC vessel SCFAs increased regularly up to nine days of feeding, and the levels of
SCFAs rose in both PC and DC over the course of the experiment. This effect may again be due to
polysaccharides in PM, used as a carbon source by the microbial population.
Overall, neither extract had any relevant effects on normal levels of SCFA and NH4+ after
administration of a relatively high level of total phenols (390.4 mg/day for OP and 240.4 mg/day for PM).
Compared to PC and DC in controls, only slight increases were recorded and no antimicrobial effect was
observed at these doses. It can be affirmed that OP and PM do not affect normal microbial functionality.
2.4. Changes in Microbial Composition by Illumina
As shown in Figure 3, a clusterization was observed for the control and two samples at the
same times both for proximal and distal samples, confirming that no significant changes occurred to
microbial composition; the family distribution confirmed the information from cluster dendrograms
(Supplementary Materials Figure S2).
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Figure 3. Cluster dendrogram of microbial composition from Illumina sequencing of SHIME® 
samples (obtained as mean sample by the union of two replicas) after feeding with OP and PM 
extracts. 
Positive modifications were induced with subtle changes in relative abundance of certain 
bacteria, with a more relevant effect of PM with respect to OP, particularly after nine days of feeding. 
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Positive modifications were induced with subtle changes in relative abundance of certain bacteria,
with a more relevant effect of PM with respect to OP, particularly after nine days of fee ing. The relative
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abundance of different families in distal vessels treated with the two extracts indicated a reduction of
Fusobacteriaceae (Figure 4a), a pro-inflammatory and invasive family associated with IBD and acute
appendicitis [41].
A significant increase of Lactobacillaceae and Bifidobacteriaceae was observed only in PCOP (Figure 4b).
Furthermore, the ratio Firmicutes/Bacteroidetes was influenced by both the extracts at the distal level,
with a decrease of the value during treatment and washout (Figure 4c). The test carried out with the
feeding mixture without sugars was applied to partially simulate a diet characterized by a low energy
intake, often incorrectly proposed to reduce body weight. The evaluation of microbial functionality
(Supplementary Materials Figure S1) showed lower concentrations in control samples compared with
the complete feeding mixture (Figure 2), with an improvement in SCFAs provided by the administration
of PM for nine days, not only in the PC vessel but also in the DC sample. This result could be attributable
to the presence of the higher content of fermentable fiber (mainly pectin) in PM differently from OP, in
which this is a minority fraction of the total dietary fiber (Table 1).
Increases in Lactobacillaceae and Bifidobacteriaceae (Figure 4b) suggested a certain specificity of
the OP sample to enhance growth of these bacteria. Furthermore, the observed decrease of the
Firmicutes/Bacteroidetes ratio in the distal tract (Figure 4c) highlights a potential benefit of these samples,
since a high ratio between these families has been related to obesity risk [42].
Figure 4. Cont.
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Figure 4. Families within lumen: (a) Fusobacteriaceae after feeding with OP and PM in proximal (PC)
and distal (DC) tracts; (b) Bifidobacteriaceae and Lactobacillaceae after feeding with OP in proximal and
d stal tracts.; (c) Families withi lumen, Firmicutes/Bacteroid tes ratio n distal tract after feeding with
OP and PM.
The role played by the carbohydrate fraction in pomegranate decoction and olive pâté was
preliminarily evaluated by testing no-carbohydrate feeding. The results, as shown in Supplementary
Materials Figure S1, suggested that part of these polysaccharides was used as carbon source by
int stinal bact ria, in proximal and distal tracts, to maintain a stable level of SCFA and contrast the
negative effects of extreme di ts ( igh proteins/no sugars) on gut wellness.
2.5. Polyphenol Metabolic Fate
Samples from different vessels and times (PC-OP day 9, DC-OP day 9, PC-PM day 9, and DC-PM
day 9) and control samples (PC-OP and PC-PM) were treated before the analysis to precipitate soluble
proteins and were analyzed by HPLC-DAD/MS-TOF with HP 1100 liquid chromatography coupled
with HP 6200 series MS-TOF (Agilent Technologies, CA, USA). Hydroxytyrosol was detected in PC-OP
(Figure 5a) according to its rt value, and mass spectrum (ions [M − H]− at 153.05 m/z and [2M − H] − at
307.12 m/z). In the PC-OP day 9 sample, the concentration of hydroxytyrosol decreased and a new
compound, corresponding to tyrosol (molecular ion at 137.06 m/z, dimer at 272.13 m/z), appeared in
both PC and DC samples. Presumably due to its low concentration in OP (Table 1) and a possible
fragmentation according to the scheme in Supplementary Materials Figure S3, verbascoside was
undetectable, while by applying extract ion processing, the ion species at 179.15 m/z ascribable to
caffeic acid was detected in PC-OP and DC-OP samples after nine days. Our evidence agrees with the
presence of well-known esterases, which are normally active in microbiota and able to hydrolyze several
phenolic compounds [43], such as verbascoside and secoiridoidic derivatives, both of ligstroside and
oleuropein (producing free hydroxytyrosol and tyrosol). Analogously to verbascoside, the secoiridoidic
derivatives were completely absent in all the vessels due to the esterase action, but also because they
are very unstable molecules.
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and verbascoside (3). (b) MS spectra of compounds 1 and 2 with the dimeric forms.
Hydroxytyrosol was partially metabolized at the proximal level, but was not detected in the distal
sample, indicating a complete metabolization at this level. This result does not agree with Mosele and
co-workers [31], who found hydroxytyrosol in fecal samples. Conversely, other groups [32] pointed out
a significantly higher level of tyrosol in human plasma and urine after an intake of biscuits enriched
with olive phenols. The same authors underlined how this metabolite partially derives from colonic
metabolism. Our results from the SHIME® system agree with these latter in vivo findings, confirming
this system as a suitable tool to simulate the human colonic metabolism before intervention studies.
Furthermore, the biotransformation of OP polyphenols by the gut microbial community can help to
increase the antioxidant potential in the intestinal lumen due to the release of small phenols by esterase
action. Hydroxytyrosol, which rapidly oxidizes as pure standard in water solution, was detected at the
distal colon, confirming the stability of the molecule in anaerobic conditions.
Regarding PM, the chromatographic profile of the proximal vessel after nine days of feeding
(PC-PM day 9) showed again ellagic acid as the main phenol, as obtained at time 0 (PC-PM); ellagic
acid was easily detectable at rt 15 min, by the [M − H]− ion at 301 m/z. The absence of punicalagins,
not detected in PC and DC vessels (Figure 6a) also at time 0, was correlated to their well-known ability
to form insoluble complexes with soluble proteins [44] that are highly included in liquid luminal
suspension. In any case, punicalagins (free or complexed with proteins) interacted with the colonic
microbiota because in DC two main metabolites of these ellagitannins were identified: urolithins C
and A (Figure 6a).
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As expected, the profile of the distal colon, derived after a longer exposure to microbiota
metabolism (DC-PM day 9), was different. The ellagic acid disappeared, and two new metabolites
were detected and identified (Figure 6A and Supplementary Materials Figure S4), according to UV-Vis
spectra and literature data [16], as urolithin A and urolithin C. Their mass spectra (Figure 6B), showing
the molecular ions (at 227.03 m/z and 243.03 m/z respectively) and the corresponding two dimers
([2M − H]−), further confirmed the identification. Our result is consistent with previous in vivo studies
that showed the metabolic path of pomegranate ellagitannins to urolithins in the distal intestinal
tract [28,45]. Once again, the SHIME® system was effective in identifying the metabotype of the human
donor [16]. Only urolithins C and A were produced in the distal tract, without traces of urolithin B
(Figure 6), indicating the presence of metabotype A. Compared to Garcia-Villalba et al. [16], in our
work the composition of the tested sample (PM) was very different. In particular, a lower dose of
punicalagin was administered per day (30% less) and for a shorter time (nine instead of twenty one
days), the amount of ellagic acid and its glycosides was nine times lower (20 mg instead of 180 mg per
day), and finally approximately 200 mg of polysaccharides per day were present in the sample and
were administered. In agreement with García-Villalba et al. [16], the punicalagins, although in higher
amounts and administered for a longer time, were not detected in the distal tract. At the same time,
unlike García-Villalba et al. [16], we observed little increase in SCFAs in the proximal tract (Figure 2A),
presumably due to the co-presence of pectin, but also to a lower amount of ellagitannins (both as
quantity/day and total days of administration), which could exert moderate antimicrobial effects at
high doses. Furthermore, we observed how a carbohydrate-free diet associated with a lower dose
of ellagitannins was again able to show an increase in SCFA production over time (Supplementary
Materials Figure S1).
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3. Materials and Methods
3.1. Pomegranate and Olive By-Products
Pomegranate fruits (Wonderful cv) cultivated on farms in Tuscany, were harvested in Grosseto
(Tuscany, Italy). The mesocarp was manually separated from the other parts, then a 1 h decoction was
applied [10]; the suspension was freeze-dried, ground, and used as powder (PM). The olive “pâté”
was obtained from a milling process with biphasic decanter and a final separator “Leopard” (Pieralisi,
Italy); the sample, including only wet pulp and husk, was freeze-dried. The powder was washed by
adding n-hexane (15 mL/g) and stirring for 1 h to remove lipid fractions, and the residual powder was
used for the experiments (OP).
Polysaccharide content was determined after ethanol precipitation, and in accordance with the
literature was mainly constituted by pectin [10,34,35].
3.2. Standards
The following pure standards were used for qualitative and quantitative analyses: α + β
punicalagins, ellagic acid, hydroxytyrosol, tyrosol, oleuropein, and caffeic acid, all purchased from
Sigma Aldrich (St. Louis, MO, USA).
3.3. SHIME® Experiments
Two replicates of a triple SHIME® experiment were performed at different times, using fecal
samples from the same healthy donor as inoculum to simulate a traditional luminal microbial
community [46]. The SHIME® also contained mucin microcosms (K1-carrier, AnoxKaldnes AB, Lund,
Sweden), submerged in mucin-agar to host surface-attached microbes [47]. The feed selected included
(g/L): arabinogalactan (1), pectin (2), xylan (1), D-(+)-glucose (0.4), starch (4), yeast extract (3.0), peptone
(1.0), and pig gastric mucin (4.0). Proximal colon (PC) vessels were filled with 500 mL of feed and
80 microcosms, while distal colon (DC) units were filled with 800 mL of feed and the same amount
of mucin. Inoculation was performed with 40 mL of a 1:5 dilution of fresh stools [48]. Three series
of colon vessels (proximal and distal) ran simultaneously: one pair for control, one for OP, and the
third for PM treatment (Figure 1). After 18 h incubation for pH stabilization, 140 mL of nutritional
medium and 60 mL of pancreatic juice were supplied to each colon compartment three times per
day. The system was kept at 37 ◦C under anaerobic conditions. In the first 2 weeks the system was
stabilized, then daily doses of the extract were administered to the PC vessel for 10 days, while the
control PC did not receive any administrations in the same period. At the end of the treatment, a 4 day
washout was carried out. Experiments were performed with different extract dosages: 4 g/L of OP and
2 g/L of PM. Three times per week, at the same time every day, 20 mL of liquid sample were collected
from each colon vessel (Figure 1). Then 1 mL was centrifuged, and the pellet saved. All samples were
stored with residual liquid at −20 ◦C.
Tests with No-Carb Diet
The experiments described above, using the same amount of the two extracts (4 g/L of OP and
2 g/L of PM), were also carried out providing a feed without a carbohydrate fraction. The SHIME®
contained a special feed without sugars included: yeast extract 3.0 g/L, peptone 1.0 g/L, and pig gastric
mucin 4.0 g/L.
For each experiment, after a stabilization period of 2 weeks, daily doses of extracts were
administrated directly to the PC vessel for 10 days.
3.4. HPLC/DAD/MS Analysis of Phenolic Compounds
Solvents and standards of analytical purity were purchased from Sigma Aldrich (St. Louis, MO,
USA). The control samples (PCC) were added with fresh extracts at the same concentrations used for
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experiments, to evaluate starting point profiles (PCC_OP and PCC_PM). These samples were then
compared with proximal and distal samples recovered during treatment with extracts (PCOP_d9,
DCOP_d9, PCPM_d9, and DCDM_d9). Samples of vessel content collected before the administration
were also analyzed to evaluate possible interferences due to feed components.
All samples were pre-treated in order to obtain a clear solution, adding a mix of
acetone/acetonitrile/methanol 1:1:1, as described previously [49]. Samples from vessels administered
with PM received the same treatment, but the original supernatant was also acidified with HCOOH.
The suspension was then centrifuged at 4 ◦C, 5000 rpm, 10 min. Then, 1 mL of supernatant was
recovered and dried using N2 gas. The dried residue was dissolved in 200 µL of ethanol/acidic
water (by HCOOH) 7:3 v/v. Final ultracentrifugation (10 min, 14,000 rpm) was applied to obtain clear
samples for HPLC. The analyses were performed using an HP 1100 liquid chromatography (Agilent
Technologies, USA) coupled with HP 6200 series MS-TOF.
For OP treated samples, a 150 mm × 3 mm i.d., 2.7 µm, RP-18, Poroshell column (Agilent
Technologies, USA) was used. Eluents selected were (A) H2O at pH 3.2 by formic acid and (B) CH3CN.
The multi-step linear solvent gradient used was: 0–40 min 5–40% B; 40–45 min, 40% B; 45–50 min
40–100% B; 50–53 min 100%; 53–55 min 100–5%, equilibration time 10 min; flow rate 0.4 mL/min.
The UV–Vis spectra were recorded in the range 200–600 nm and the chromatograms were acquired at
240 nm, 280 nm, 330 nm, and 350 nm. MS spectra were acquired using Dual-ESI source in negative
polarity, with an 80 V fragmentor, 3800 V capillary voltage, 350 ◦C of gas temperature. For quantitative
analysis of OP samples, hydroxytyrosol and tyrosol were quantified using a calibration curve of tyrosol
standard with R2 = 0.999 at 280 nm. Oleuropein derivatives (280 nm) were quantified by applying a
four-point calibration curve obtained with standard oleuropein with R2 = 0.999. Verbascoside and
derivatives were determined using a caffeic acid calibration curve at 330 nm with R2 = 0.999.
PM treated samples were analyzed using a 150 mm × 2 mm i.d., 4 µm, RP-18, Sinergi Fusion
column (Phenomenex, Torrance, CA, USA). As seen for OP samples analysis, (A) H2O at pH 3.2 by
formic acid and (B) CH3CN were selected as eluents. The multi-step linear solvent gradient used
was: 0–4 min 5–25% B; 4–8 min, 25–25% B; 8–14 min 25–35% B; 14–16 min 35–90%; 16–18 min 90–5%,
equilibration time 10 min; flow rate 0.4 mL/min. The UV–Vis spectra were recorded in the range
200–500 nm and the chromatograms were acquired at 240 nm, 280 nm, 330 nm, 370 nm, and 380 nm.
MS spectra were acquired using Dual-ESI source in negative polarity with a 100 V fragmentor, 4000 V
capillary voltage, 350 ◦C of gas temperature. Quantitative analysis of PM components was performed
using α + β punicalagins (380 nm) in a linearity range between 0.5 and 8 µg with an R2 = 0.9994; the
calibration curve of ellagic acid (370 nm) was in the linearity range of 0.031–1.25 µg with an R2 = 0.9995.
3.5. SCFA and NH4+
For SCFA analysis, a liquid-liquid extraction with diethyl ether was used, after the addition
of H2SO4 and internal standard. SCFA quantitative analysis was performed by capillary gas
chromatography coupled with a flame ionization detector (GC-FID), as previously described [50].
Ammonium levels were analyzed by steam distillation according to standard methods 4500-NH3
B [50]. Determination of total ammoniacal nitrogen (TAN) in liquid luminal samples was performed
through NH4+ quantification by the addition of MgO, distillation of NH3 into boric acid solution and
subsequent back-titration.
SCFA and NH4+ values obtained from the two experiments were reported as average ±
standard deviation.
3.6. DNA Extraction
Bacterial DNA from luminal samples was extracted as described earlier [51], using a lysis buffer
(TrisEDTA, NaCl, PVP40, SDS, water, (Milford, MA, USA)) and glass beads for FastPrep. Extraction
was performed with phenol-chloroform, and EtOH/NaOAc was used for precipitation [52]. Samples
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were dissolved in TrisEDTA 1X and stored at −20 ◦C. Concentration and quality were verified by
Nanodrop (Thermo Scientific, Beverly, MA, USA) and 2% agarose gel electrophoresis.
3.7. Illumina Sequencing Samples from SHIME
The samples from the two experiments were pooled and the V5–V6 hypervariable regions of the
16S rRNA gene were PCR-amplified and sequenced by MiSeq Illumina (Illumina, Inc., San Diego,
CA, USA) using a 250 bp × 2 paired-end protocol. The multiplexed libraries were prepared using
the 783F and 1046R primers [53,54]. The PCR was performed in 2 × 50 µL reactions with GoTaq
Green Master Mix (Promega Corporation, Madison, WI, USA) and 1 µM of each primer as previously
reported [55]. The amplicons were purified with the Wizard SV Gel and PCR Clean-up System (Promega
Corporation, Madison, WI, USA,) according to the manufacturer’s instructions, and quantified using
Qubit (Life Technologies, Carlsbad, CA, USA). All DNA samples were tested for amplification inhibition
by sample dilution. DNA sequencing was carried out at Parco Tecnologico Padano (Lodi, Italy). Reads
from sequencing were demultiplexed and bioinformatic elaborations were performed as previously
reported [56]. Operational Taxonomic Units (OTUs) were defined on the whole data set clustering
the sequences at 97% sequence identity and defining a representative sequence for each cluster.
The abundance of each OTU was estimated by mapping the sequences of each sample against the
representative sequence of each OTU at 97% sequence identity. Classification of the sequences
representative of each OTU at different taxonomic ranks was done using the RDP classifier (≥80%
confidence) [57]. A cluster analysis (CA) based on Hellinger transformed family relative abundance
data was performed using the vegan package [58] in R 3.5.1 [59].
4. Conclusions
These by-products from olive and pomegranate food processing, characterized by the co-presence
of phenolic components and polysaccharides, were evaluated for the first time for their interaction with
human microbiota after repeated administration using the in vitro SHIME® system. We demonstrated
that the selected doses of olive and pomegranate, after repeated daily administration, do not have
antimicrobial effects on the colonic microbial community because the SCFAs production was not reduced.
On the contrary, they determined some positive changes, such as the reduction of Fusobacteriaceae
(associated with an inflammatory status) or the net increase in Lactobacillaceae and Bifidobacteriaceae, as
in the case of olive pâté. Even in a more critical condition, such as a no-carbohydrate diet, microbial
functionality and gut wellness were maintained as confirmed by the SCFA production. Regarding the
pomegranate extract, the structure of the urolithins produced in the SHIME® system confirmed the
presence of metabotype A. Furthermore, the fate of polyphenols included in olive pâté was found to be
congruous with enzymatic pathways already observed in in vivo studies; tyrosol as main metabolite in
distal colon was highlighted for the first time. Although this in vitro system clearly has limitations in
reproducing all the interactions and mechanisms involved in the human gut, the obtained information
is consistent with results from previous in vivo studies.
Our data suggested that the repeated administration of these samples, obtained from agricultural
by-products using simple and green processes, can be suitable as new functional food ingredients to
provide a daily intake of beneficial polyphenols and fermentable polysaccharides as in the case of
pomegranate extract. Further in vivo studies on standardized samples obtained as blends of extracts
from more batches of olive pâté and pomegranate peel are required to demonstrate if the tested
by-products are safe for administration in dietary supplements.
Supplementary Materials: The following are available online: Figure S1. SCFA levels; Figure S2. Microbial
distribution, and Figure S3, S4: Chemical structure of the main phenols.
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